Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences

L Collette; U Struder; Fritz Schröder; LJ Denis; RJ Sylvester

doi:10.1002/pros.1078

Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences

L Collette
, U Struder
, Fritz Schröder
, LJ Denis
, RJ Sylvester

Urology

Research output: Contribution to journal › Article › Academic › peer-review

26 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	29-39
Number of pages	11
Journal	Prostate
Volume	48
Issue number	1
DOIs	https://doi.org/10.1002/pros.1078
Publication status	Published - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/pros.1078

http://hdl.handle.net/1765/63475

Cite this

@article{40538f991ea548acba43402986ea527f,

title = "Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences",

author = "L Collette and U Struder and Fritz Schr{\"o}der and LJ Denis and RJ Sylvester",

year = "2001",

doi = "10.1002/pros.1078",

language = "Undefined/Unknown",

volume = "48",

pages = "29--39",

journal = "Prostate",

issn = "0270-4137",

publisher = "John Wiley \& Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences

AU - Collette, L

AU - Struder, U

AU - Schröder, Fritz

AU - Denis, LJ

AU - Sylvester, RJ

PY - 2001

Y1 - 2001

U2 - 10.1002/pros.1078

DO - 10.1002/pros.1078

M3 - Article

SN - 0270-4137

VL - 48

SP - 29

EP - 39

JO - Prostate

JF - Prostate

IS - 1

ER -